

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 7.69783722 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.66960292 |
| 3 | B cell mediated immunity (GO:0019724) | 6.09325119 |
| 4 | positive regulation of mast cell degranulation (GO:0043306) | 5.26563599 |
| 5 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 5.26563599 |
| 6 | interferon-gamma-mediated signaling pathway (GO:0060333) | 5.20463565 |
| 7 | regulation of hypersensitivity (GO:0002883) | 5.18942660 |
| 8 | positive regulation of mast cell activation (GO:0033005) | 5.08766886 |
| 9 | positive regulation of antigen processing and presentation (GO:0002579) | 4.81682312 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.80794717 |
| 11 | regulation of antigen processing and presentation (GO:0002577) | 4.27094689 |
| 12 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.25835160 |
| 13 | response to peptidoglycan (GO:0032494) | 4.23056105 |
| 14 | regulation of mast cell activation (GO:0033003) | 4.17923275 |
| 15 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 4.07655362 |
| 16 | cellular response to interferon-gamma (GO:0071346) | 4.02739425 |
| 17 | mast cell activation (GO:0045576) | 3.94745678 |
| 18 | myeloid cell activation involved in immune response (GO:0002275) | 3.94306694 |
| 19 | detection of bacterium (GO:0016045) | 3.93578753 |
| 20 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.93422967 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.93058105 |
| 22 | regulation of mast cell degranulation (GO:0043304) | 3.92700095 |
| 23 | positive regulation of type 2 immune response (GO:0002830) | 3.89604730 |
| 24 | T cell costimulation (GO:0031295) | 3.88513145 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 3.87978368 |
| 26 | mature B cell differentiation involved in immune response (GO:0002313) | 3.87820153 |
| 27 | cellular extravasation (GO:0045123) | 3.86561665 |
| 28 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.83274136 |
| 29 | lymphocyte costimulation (GO:0031294) | 3.83016669 |
| 30 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.81596679 |
| 31 | neutrophil activation (GO:0042119) | 3.81350406 |
| 32 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.77727312 |
| 33 | positive thymic T cell selection (GO:0045059) | 3.75173492 |
| 34 | detection of other organism (GO:0098543) | 3.73509824 |
| 35 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.68492927 |
| 36 | negative regulation of B cell apoptotic process (GO:0002903) | 3.67365826 |
| 37 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.65232297 |
| 38 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.59372834 |
| 39 | response to interferon-gamma (GO:0034341) | 3.58407732 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.54020421 |
| 41 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.53534352 |
| 42 | regulation of B cell differentiation (GO:0045577) | 3.52717908 |
| 43 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.51055189 |
| 44 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.47015734 |
| 45 | granulocyte activation (GO:0036230) | 3.45116204 |
| 46 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.43092828 |
| 47 | positive regulation of leukocyte degranulation (GO:0043302) | 3.42393621 |
| 48 | cell wall macromolecule catabolic process (GO:0016998) | 3.40843992 |
| 49 | negative regulation of interleukin-12 production (GO:0032695) | 3.37346939 |
| 50 | detection of external biotic stimulus (GO:0098581) | 3.34797525 |
| 51 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.31793337 |
| 52 | regulation of growth of symbiont in host (GO:0044126) | 3.31793337 |
| 53 | negative regulation of growth of symbiont in host (GO:0044130) | 3.31793337 |
| 54 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.31793337 |
| 55 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.31607151 |
| 56 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.29094161 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.28658486 |
| 58 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.28003576 |
| 59 | regulation of leukocyte degranulation (GO:0043300) | 3.26561103 |
| 60 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.24657365 |
| 61 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.24657365 |
| 62 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.24657365 |
| 63 | modulation by symbiont of host immune response (GO:0052553) | 3.24657365 |
| 64 | positive regulation by symbiont of host defense response (GO:0052509) | 3.24657365 |
| 65 | modulation by symbiont of host defense response (GO:0052031) | 3.24657365 |
| 66 | defense response to protozoan (GO:0042832) | 3.23464393 |
| 67 | regulation of T cell tolerance induction (GO:0002664) | 3.21365159 |
| 68 | microglial cell activation (GO:0001774) | 3.18807471 |
| 69 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.17581692 |
| 70 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.16884662 |
| 71 | NAD biosynthetic process (GO:0009435) | 3.16575914 |
| 72 | mature B cell differentiation (GO:0002335) | 3.16092831 |
| 73 | regulation of tolerance induction (GO:0002643) | 3.15062331 |
| 74 | respiratory burst (GO:0045730) | 3.14499805 |
| 75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.13013485 |
| 76 | response to protozoan (GO:0001562) | 3.07740973 |
| 77 | production of molecular mediator of immune response (GO:0002440) | 3.05453551 |
| 78 | detection of biotic stimulus (GO:0009595) | 3.04977960 |
| 79 | leukocyte degranulation (GO:0043299) | 3.04132302 |
| 80 | positive regulation of macrophage cytokine production (GO:0060907) | 3.03971623 |
| 81 | T cell activation involved in immune response (GO:0002286) | 3.01383427 |
| 82 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.00290361 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.99212481 |
| 84 | mast cell activation involved in immune response (GO:0002279) | 2.98429058 |
| 85 | mast cell degranulation (GO:0043303) | 2.98429058 |
| 86 | B cell receptor signaling pathway (GO:0050853) | 2.97462382 |
| 87 | cellular response to exogenous dsRNA (GO:0071360) | 2.97279247 |
| 88 | T-helper 1 type immune response (GO:0042088) | 2.97042103 |
| 89 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.95871995 |
| 90 | response to hydroperoxide (GO:0033194) | 2.95642436 |
| 91 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93637308 |
| 92 | regulation of type 2 immune response (GO:0002828) | 2.92605778 |
| 93 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.92327951 |
| 94 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91569944 |
| 95 | response to host immune response (GO:0052572) | 2.91569944 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.91364983 |
| 97 | myeloid dendritic cell activation (GO:0001773) | 2.89801068 |
| 98 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.88265919 |
| 99 | peptide catabolic process (GO:0043171) | 2.85875890 |
| 100 | positive regulation of interferon-gamma production (GO:0032729) | 2.85807460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.56509833 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.78443739 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.53482037 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.22055674 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.42127781 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.41893589 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.35145737 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28743619 |
| 9 | SPI1_23547873_ChIP-Seq_NB4_Human | 3.13989889 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.06953828 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 3.05590961 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93080346 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.82142553 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.62116050 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.55005038 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.48689320 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35543521 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.32613618 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32272380 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27294407 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.24249434 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.23823680 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.15068444 |
| 24 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.14219289 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08014987 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04914724 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.01362562 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98023860 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96080956 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94356190 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.93523524 |
| 32 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.90674431 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79975923 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79744019 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78703464 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.77046559 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.73002245 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.71423140 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70765481 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68637805 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.64614778 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.61283359 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56090441 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51192013 |
| 45 | MYC_22102868_ChIP-Seq_BL_Human | 1.46422407 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.44987727 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42748166 |
| 48 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34447007 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33905014 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32418928 |
| 51 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.29862673 |
| 52 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27268836 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.23649954 |
| 54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22659712 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21272085 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18686112 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18070781 |
| 58 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17813998 |
| 59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15909889 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13982524 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11735649 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11430379 |
| 63 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09887572 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.09740097 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08566876 |
| 66 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08283424 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07335339 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05758397 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05517052 |
| 70 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.03296894 |
| 71 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02113918 |
| 72 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00065238 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00010519 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99775705 |
| 75 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99096960 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98967715 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97265530 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95305416 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94612731 |
| 80 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94021316 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93260599 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92887665 |
| 83 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92342069 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91835953 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90824610 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90162408 |
| 87 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89942753 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88127000 |
| 89 | P300_27268052_Chip-Seq_Bcells_Human | 0.87596324 |
| 90 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.87395535 |
| 91 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86413907 |
| 92 | GATA3_26560356_Chip-Seq_TH1_Human | 0.85367969 |
| 93 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.84697708 |
| 94 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81432895 |
| 95 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.81151436 |
| 96 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.78987631 |
| 97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.77939367 |
| 98 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.77895341 |
| 99 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76898993 |
| 100 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.74030164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.12785733 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.25557083 |
| 3 | MP0005451_abnormal_body_composition | 3.17799087 |
| 4 | MP0005671_abnormal_response_to | 3.15449744 |
| 5 | MP0001800_abnormal_humoral_immune | 3.07400168 |
| 6 | MP0002419_abnormal_innate_immunity | 3.02556535 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.91587838 |
| 8 | MP0009785_altered_susceptibility_to | 2.82749402 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.82666902 |
| 10 | MP0005025_abnormal_response_to | 2.76169197 |
| 11 | MP0003436_decreased_susceptibility_to | 2.75802709 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.66057899 |
| 13 | MP0002723_abnormal_immune_serum | 2.65232776 |
| 14 | MP0001790_abnormal_immune_system | 2.42990367 |
| 15 | MP0005387_immune_system_phenotype | 2.42990367 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.42018207 |
| 17 | MP0001819_abnormal_immune_cell | 2.40125379 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.35334616 |
| 19 | MP0006082_CNS_inflammation | 2.28077140 |
| 20 | MP0003724_increased_susceptibility_to | 2.20712439 |
| 21 | MP0009764_decreased_sensitivity_to | 2.08223292 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.00582284 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 1.91929831 |
| 24 | MP0001545_abnormal_hematopoietic_system | 1.91929831 |
| 25 | MP0002398_abnormal_bone_marrow | 1.91328499 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.91213242 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.88791621 |
| 28 | MP0000716_abnormal_immune_system | 1.85465439 |
| 29 | MP0003075_altered_response_to | 1.78426852 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.77401261 |
| 31 | MP0009278_abnormal_bone_marrow | 1.77275225 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 1.75560314 |
| 33 | MP0000685_abnormal_immune_system | 1.75388625 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.71359463 |
| 35 | MP0003303_peritoneal_inflammation | 1.64226312 |
| 36 | MP0003866_abnormal_defecation | 1.61554736 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.61374358 |
| 38 | MP0008469_abnormal_protein_level | 1.60624556 |
| 39 | MP0001853_heart_inflammation | 1.59574039 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.58122037 |
| 41 | MP0002405_respiratory_system_inflammati | 1.55914008 |
| 42 | MP0002429_abnormal_blood_cell | 1.53777816 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.48164783 |
| 44 | MP0000858_altered_metastatic_potential | 1.46825607 |
| 45 | MP0005166_decreased_susceptibility_to | 1.45018355 |
| 46 | MP0002722_abnormal_immune_system | 1.34953471 |
| 47 | MP0000343_altered_response_to | 1.30418108 |
| 48 | MP0003828_pulmonary_edema | 1.29433314 |
| 49 | MP0001986_abnormal_taste_sensitivity | 1.28151191 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.26897075 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.25855787 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.23741279 |
| 53 | MP0002006_tumorigenesis | 1.21248311 |
| 54 | MP0001542_abnormal_bone_strength | 1.19705949 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.15605277 |
| 56 | MP0005165_increased_susceptibility_to | 1.08572449 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.07595806 |
| 58 | MP0004883_abnormal_blood_vessel | 1.06527706 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.00017080 |
| 60 | MP0008057_abnormal_DNA_replication | 0.98839857 |
| 61 | MP0009763_increased_sensitivity_to | 0.97728731 |
| 62 | MP0000703_abnormal_thymus_morphology | 0.97144310 |
| 63 | MP0002009_preneoplasia | 0.97074820 |
| 64 | MP0009115_abnormal_fat_cell | 0.96999337 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 0.93206318 |
| 66 | MP0002822_catalepsy | 0.91200292 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 0.89240045 |
| 68 | MP0004084_abnormal_cardiac_muscle | 0.89006418 |
| 69 | MP0003183_abnormal_peptide_metabolism | 0.87454422 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 0.86968038 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 0.86737980 |
| 72 | MP0002019_abnormal_tumor_incidence | 0.83055115 |
| 73 | MP0004947_skin_inflammation | 0.82229432 |
| 74 | MP0000249_abnormal_blood_vessel | 0.78807138 |
| 75 | MP0000371_diluted_coat_color | 0.78111378 |
| 76 | MP0001873_stomach_inflammation | 0.77671947 |
| 77 | MP0005535_abnormal_body_temperature | 0.72830609 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 0.71379002 |
| 79 | MP0003186_abnormal_redox_activity | 0.70360329 |
| 80 | MP0005164_abnormal_response_to | 0.68521027 |
| 81 | MP0008007_abnormal_cellular_replicative | 0.68126726 |
| 82 | MP0009379_abnormal_foot_pigmentation | 0.67150381 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.66822506 |
| 84 | MP0003448_altered_tumor_morphology | 0.66361961 |
| 85 | MP0004381_abnormal_hair_follicle | 0.65063126 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 0.64982291 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.64267198 |
| 88 | MP0001663_abnormal_digestive_system | 0.63759411 |
| 89 | MP0000490_abnormal_crypts_of | 0.62895781 |
| 90 | MP0000569_abnormal_digit_pigmentation | 0.62373961 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 0.62103227 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59819126 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.56872183 |
| 94 | MP0008873_increased_physiological_sensi | 0.56779632 |
| 95 | MP0005647_abnormal_sex_gland | 0.56685520 |
| 96 | MP0002132_abnormal_respiratory_system | 0.56387363 |
| 97 | MP0003045_fibrosis | 0.56119992 |
| 98 | MP0006072_abnormal_retinal_apoptosis | 0.55876346 |
| 99 | MP0000920_abnormal_myelination | 0.52577643 |
| 100 | MP0005334_abnormal_fat_pad | 0.51060296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic obstructive pulmonary disease (HP:0006510) | 5.18562342 |
| 2 | Obstructive lung disease (HP:0006536) | 5.18562342 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.70058591 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.65988488 |
| 5 | Amyloidosis (HP:0011034) | 4.42309724 |
| 6 | Abnormality of the prostate (HP:0008775) | 4.33787759 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 4.31676636 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.20728660 |
| 9 | Meningitis (HP:0001287) | 4.07371087 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.04525117 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.00912916 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 4.00912916 |
| 13 | Chest pain (HP:0100749) | 3.93414758 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.89856133 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.78997391 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.65355442 |
| 17 | Hemoptysis (HP:0002105) | 3.62686278 |
| 18 | Pulmonary infiltrates (HP:0002113) | 3.60527662 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.57010177 |
| 20 | Ureteral stenosis (HP:0000071) | 3.52356104 |
| 21 | Ureteral obstruction (HP:0006000) | 3.41403981 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.32366571 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.30327575 |
| 24 | Recurrent skin infections (HP:0001581) | 3.29512271 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.25369885 |
| 26 | Vasculitis (HP:0002633) | 3.21293377 |
| 27 | Urticaria (HP:0001025) | 3.06289527 |
| 28 | Agammaglobulinemia (HP:0004432) | 3.01087219 |
| 29 | Stomatitis (HP:0010280) | 3.01037283 |
| 30 | Abnormality of the pleura (HP:0002103) | 2.95627287 |
| 31 | Colitis (HP:0002583) | 2.95259491 |
| 32 | Epistaxis (HP:0000421) | 2.93745258 |
| 33 | Pulmonary embolism (HP:0002204) | 2.89150589 |
| 34 | Acute lymphatic leukemia (HP:0006721) | 2.84439851 |
| 35 | Macular degeneration (HP:0000608) | 2.82179851 |
| 36 | Recurrent viral infections (HP:0004429) | 2.78743298 |
| 37 | Basal ganglia calcification (HP:0002135) | 2.75514944 |
| 38 | Polygenic inheritance (HP:0010982) | 2.75113558 |
| 39 | Chronic sinusitis (HP:0011109) | 2.74827185 |
| 40 | B lymphocytopenia (HP:0010976) | 2.71479561 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.67742434 |
| 42 | Abnormality of male internal genitalia (HP:0000022) | 2.66240459 |
| 43 | Fatigue (HP:0012378) | 2.62815192 |
| 44 | Gangrene (HP:0100758) | 2.62360544 |
| 45 | Thrombocytosis (HP:0001894) | 2.62325503 |
| 46 | Spondylolisthesis (HP:0003302) | 2.61427251 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.61005115 |
| 48 | Granulocytopenia (HP:0001913) | 2.59130461 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.57435686 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.53458478 |
| 51 | Gastrointestinal infarctions (HP:0005244) | 2.49815871 |
| 52 | Pulmonary fibrosis (HP:0002206) | 2.48670531 |
| 53 | Exertional dyspnea (HP:0002875) | 2.45015875 |
| 54 | Skin rash (HP:0000988) | 2.41394746 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.39972843 |
| 56 | Encephalitis (HP:0002383) | 2.39883109 |
| 57 | Abolished electroretinogram (ERG) (HP:0000550) | 2.38224359 |
| 58 | Petechiae (HP:0000967) | 2.37780791 |
| 59 | Gingival bleeding (HP:0000225) | 2.37732078 |
| 60 | Porencephaly (HP:0002132) | 2.34001043 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.32992745 |
| 62 | Thrombophlebitis (HP:0004418) | 2.32471942 |
| 63 | Hepatocellular necrosis (HP:0001404) | 2.30962825 |
| 64 | Hypoplasia of the thymus (HP:0000778) | 2.29447515 |
| 65 | Acute myeloid leukemia (HP:0004808) | 2.23043031 |
| 66 | Xerostomia (HP:0000217) | 2.22910701 |
| 67 | Myositis (HP:0100614) | 2.22101694 |
| 68 | Severe combined immunodeficiency (HP:0004430) | 2.22073058 |
| 69 | Cone-rod dystrophy (HP:0000548) | 2.19866812 |
| 70 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19148175 |
| 71 | Absent/shortened dynein arms (HP:0200106) | 2.19148175 |
| 72 | Gingivitis (HP:0000230) | 2.18607479 |
| 73 | Recurrent bronchitis (HP:0002837) | 2.17296636 |
| 74 | Purpura (HP:0000979) | 2.16217610 |
| 75 | Progressive visual loss (HP:0000529) | 2.13628843 |
| 76 | Polyneuropathy (HP:0001271) | 2.13270168 |
| 77 | Mutism (HP:0002300) | 2.12544592 |
| 78 | Abnormality of glycolipid metabolism (HP:0010969) | 2.12252362 |
| 79 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.12252362 |
| 80 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.12252362 |
| 81 | Restrictive lung disease (HP:0002091) | 2.11718997 |
| 82 | Metaphyseal dysplasia (HP:0100255) | 2.05808715 |
| 83 | Leukocytosis (HP:0001974) | 2.02968841 |
| 84 | Alveolar cell carcinoma (HP:0006519) | 2.02326557 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.00285349 |
| 86 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.98546707 |
| 87 | Abnormality of T cells (HP:0002843) | 1.98539955 |
| 88 | Cerebral ischemia (HP:0002637) | 1.97153727 |
| 89 | Abnormality of the pericardium (HP:0001697) | 1.96577295 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 1.95987845 |
| 91 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.95386406 |
| 92 | Hypertensive crisis (HP:0100735) | 1.93458935 |
| 93 | Glomerulopathy (HP:0100820) | 1.93320945 |
| 94 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.92985184 |
| 95 | Cerebral hemorrhage (HP:0001342) | 1.89488906 |
| 96 | Arterial thrombosis (HP:0004420) | 1.89108580 |
| 97 | Mitochondrial inheritance (HP:0001427) | 1.88925180 |
| 98 | Dysostosis multiplex (HP:0000943) | 1.88776621 |
| 99 | T lymphocytopenia (HP:0005403) | 1.87261680 |
| 100 | Osteomyelitis (HP:0002754) | 1.85711132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BMPR2 | 5.07312489 |
| 2 | RIPK4 | 4.55777180 |
| 3 | MAP4K1 | 4.08330272 |
| 4 | KIT | 4.03642984 |
| 5 | CSF1R | 3.79037893 |
| 6 | CDK19 | 3.55085458 |
| 7 | FLT3 | 3.29510417 |
| 8 | PIK3CG | 2.93966942 |
| 9 | TYK2 | 2.48425200 |
| 10 | BLK | 2.37159835 |
| 11 | TEC | 2.04347583 |
| 12 | SYK | 2.03876750 |
| 13 | TXK | 1.89617979 |
| 14 | FES | 1.81177639 |
| 15 | JAK3 | 1.73149661 |
| 16 | IRAK4 | 1.65407163 |
| 17 | ZAP70 | 1.64380575 |
| 18 | LYN | 1.58709981 |
| 19 | BTK | 1.58593241 |
| 20 | IKBKB | 1.56494791 |
| 21 | NME2 | 1.46834227 |
| 22 | MAP3K12 | 1.45323088 |
| 23 | TLK1 | 1.44653742 |
| 24 | KDR | 1.42298951 |
| 25 | HCK | 1.33676619 |
| 26 | RPS6KA4 | 1.29234187 |
| 27 | TNK2 | 1.28005367 |
| 28 | MAP2K3 | 1.24436102 |
| 29 | MAP3K11 | 1.21258736 |
| 30 | MAP3K6 | 1.19284311 |
| 31 | LCK | 1.16703505 |
| 32 | ITK | 1.15476684 |
| 33 | GRK7 | 1.12294965 |
| 34 | CDK4 | 1.11468609 |
| 35 | TRPM7 | 1.10873087 |
| 36 | TESK2 | 1.00461647 |
| 37 | ERN1 | 0.98583369 |
| 38 | TBK1 | 0.97015887 |
| 39 | JAK1 | 0.94597323 |
| 40 | MATK | 0.89636736 |
| 41 | GRK6 | 0.83918504 |
| 42 | CSK | 0.82608690 |
| 43 | CDK6 | 0.80814622 |
| 44 | BRD4 | 0.79824230 |
| 45 | JAK2 | 0.77853251 |
| 46 | OXSR1 | 0.76634145 |
| 47 | ILK | 0.76002275 |
| 48 | IKBKE | 0.73576014 |
| 49 | CDK12 | 0.73444258 |
| 50 | ABL1 | 0.69462664 |
| 51 | CDC42BPA | 0.65741277 |
| 52 | MAP3K14 | 0.65682973 |
| 53 | MOS | 0.60820053 |
| 54 | MAP3K5 | 0.60523393 |
| 55 | MAP3K13 | 0.59024483 |
| 56 | PDK1 | 0.56692587 |
| 57 | PIM2 | 0.56595684 |
| 58 | ABL2 | 0.55860158 |
| 59 | MAP2K4 | 0.55720842 |
| 60 | PKN1 | 0.55375792 |
| 61 | MAPK7 | 0.51849482 |
| 62 | ERBB3 | 0.48096301 |
| 63 | EGFR | 0.47899710 |
| 64 | DAPK1 | 0.46585744 |
| 65 | PRKCD | 0.45715941 |
| 66 | ATR | 0.45714499 |
| 67 | IGF1R | 0.42912802 |
| 68 | TAOK3 | 0.42572500 |
| 69 | MAPK12 | 0.41976637 |
| 70 | CDK3 | 0.41778313 |
| 71 | MARK3 | 0.41350048 |
| 72 | MAP3K1 | 0.40159413 |
| 73 | PIM1 | 0.39894017 |
| 74 | DAPK3 | 0.39365233 |
| 75 | PDPK1 | 0.39054664 |
| 76 | MAP3K7 | 0.37345687 |
| 77 | CSNK1G3 | 0.37138397 |
| 78 | ADRBK2 | 0.36906797 |
| 79 | PTK2B | 0.36752954 |
| 80 | CDK9 | 0.35969265 |
| 81 | PRKD1 | 0.34953153 |
| 82 | PRKCQ | 0.33973782 |
| 83 | MARK2 | 0.33959148 |
| 84 | GRK1 | 0.32655333 |
| 85 | INSRR | 0.32561649 |
| 86 | NEK2 | 0.31687789 |
| 87 | VRK2 | 0.31598929 |
| 88 | CSNK1A1L | 0.31593750 |
| 89 | MST4 | 0.31237014 |
| 90 | MAPK4 | 0.31236996 |
| 91 | PRKG1 | 0.31149715 |
| 92 | TGFBR2 | 0.31069482 |
| 93 | CAMK1 | 0.29782620 |
| 94 | MAP3K3 | 0.29376041 |
| 95 | DYRK1B | 0.29371230 |
| 96 | MAP2K2 | 0.28795453 |
| 97 | STK24 | 0.28528599 |
| 98 | EIF2AK3 | 0.28239934 |
| 99 | RPS6KA5 | 0.27805730 |
| 100 | FYN | 0.27326866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 6.33574286 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 5.05251207 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.84392042 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.75915387 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.21315585 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.14240720 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.54030785 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 3.25678638 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 3.12074684 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.86117829 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.82069334 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.43570454 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.24509588 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.91779612 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.71582862 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.55818987 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46677201 |
| 18 | Phagosome_Homo sapiens_hsa04145 | 1.33070582 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.32606508 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.18895795 |
| 21 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.17411065 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10859319 |
| 23 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98378507 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97090543 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 0.93627685 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87406541 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82403995 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.82312182 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81690679 |
| 30 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77367345 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74164891 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68734700 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67733103 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65362861 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 0.61532162 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58033617 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 0.57594779 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 0.54877205 |
| 39 | Ribosome_Homo sapiens_hsa03010 | 0.52829261 |
| 40 | Homologous recombination_Homo sapiens_hsa03440 | 0.51107848 |
| 41 | Measles_Homo sapiens_hsa05162 | 0.49758296 |
| 42 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49663019 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 0.49302150 |
| 44 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47573910 |
| 45 | DNA replication_Homo sapiens_hsa03030 | 0.44961273 |
| 46 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43331941 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43012807 |
| 48 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39518936 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38441530 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36978003 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35313765 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.34552796 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33700288 |
| 54 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33513375 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33169049 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.31800730 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31332348 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27412332 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27136485 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26954929 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26157442 |
| 62 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26118005 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 0.24547450 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.23632637 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.22766719 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.22260651 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.21896208 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.21721272 |
| 69 | Proteasome_Homo sapiens_hsa03050 | 0.20748710 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.20148587 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17236576 |
| 72 | Salivary secretion_Homo sapiens_hsa04970 | 0.15511390 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.13827085 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.13524018 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.13326915 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.12860682 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12068876 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.11785430 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10886839 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10490995 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.10166378 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.09667002 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.09610592 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09209589 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.08052851 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06775254 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.06014419 |
| 88 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.04816316 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.03315361 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.02670594 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.02482695 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.01959990 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.01083729 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | -0.0274089 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | -0.0233023 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | -0.0196772 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | -0.0171756 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | -0.0132484 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | -0.0123181 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | -0.0088927 |

